# Survival Outcomes in Hepatocellular Carcinoma: Experience from a Multidisciplinary Committee in Ecuador

## TL;DR

A study in Ecuador finds that early detection of liver cancer through screening improves survival rates, despite cirrhosis not directly affecting outcomes.

## Contribution

The study demonstrates the importance of HCC screening in improving patient survival in a public health setting.

## Key findings

- Patients identified through HCC screening had higher survival rates over one year.
- Imaging findings of vascular invasion and extrahepatic extension were associated with survival.
- No significant link was found between cirrhosis or lab abnormalities and survival.

## Abstract

Hepatic cancer is a world health concern due to its high lethality. The main risk factor worldwide is having hepatic cirrhosis. The etiology of hepatic cirrhosis has changed in recent years, with metabolic-associated steatotic liver disease (MASLD) becoming the leading cause, displacing hepatitis C and B viruses and alcoholic liver disease. It is of the utmost importance to develop screening programs in at-risk populations for early detection. The survival rate of HCC, as determined by a group of specialists or an interdisciplinary committee, is a challenge we have taken on in a public health hospital in Ecuador. This retrospective study identified 71 patients diagnosed with hepatocellular carcinoma, mostly middle-aged men with a history of liver cirrhosis. No significant association was found between the presence of cirrhosis, laboratory abnormalities, and survival. However, the identification by imaging vascular invasion and extrahepatic extension were associated. This study highlights that patients with liver lesions identified through HCC screening have a higher survival rate over a one-year follow-up period.